share_log

Lake Street Maintains Buy on Biolase, Lowers Price Target to $0.4

Lake Street Maintains Buy on Biolase, Lowers Price Target to $0.4

Lake Street維持對Biolase的買入,將目標股價下調至0.4美元
Benzinga ·  2023/05/31 09:28

Lake Street analyst Frank Takkinen maintains Biolase (NASDAQ:BIOL) with a Buy and lowers the price target from $1.5 to $0.4.

湖街分析師弗蘭克·塔基寧維持Biolase(納斯達克股票代碼:BIOL)的買入,並將目標股價從1.5美元下調至0.4美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論